Adial Pharmaceuticals (ADIL)
(Delayed Data from NSDQ)
$1.06 USD
+0.01 (0.95%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $1.09 +0.03 (2.83%) 4:50 PM ET
4-Sell of 5 4
F Value A Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.46 | 0.00% |
Earnings Summary
For their last quarter, Adial Pharmaceuticals (ADIL) reported earnings of -$0.59 per share, missing the Zacks Consensus Estimate of -$0.39 per share. This reflects a negative earnings surprise of 51.28%. Look out for ADIL's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.46 per share, reflecting a year-over-year increase of 59.65%.
Earnings History
Price & Consensus
Zacks News for ADIL
All You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buy
ADIL: What are Zacks experts saying now?
Zacks Private Portfolio Services